SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-233350
Filing Date
2021-08-02
Accepted
2021-08-02 16:39:58
Documents
14
Period of Report
2021-08-02
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d146237d8k.htm   iXBRL 8-K 24770
2 EX-99.1 d146237dex991.htm EX-99.1 14033
6 GRAPHIC g146237g94m78.jpg GRAPHIC 2334
  Complete submission text file 0001193125-21-233350.txt   173905

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA krys-20210802.xsd EX-101.SCH 2915
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE krys-20210802_lab.xml EX-101.LAB 18887
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE krys-20210802_pre.xml EX-101.PRE 11875
7 EXTRACTED XBRL INSTANCE DOCUMENT d146237d8k_htm.xml XML 3495
Mailing Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203
Business Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 (412) 586-5830
Krystal Biotech, Inc. (Filer) CIK: 0001711279 (see all company filings)

IRS No.: 821080209 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38210 | Film No.: 211136572
SIC: 2836 Biological Products, (No Diagnostic Substances)